{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:57:55Z","timestamp":1794812275752,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neuropharm.2024.110096","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T12:52:13Z","timestamp":1722257533000},"page":"110096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease"],"prefix":"10.1016","volume":"259","author":[{"given":"Akshatha P.","family":"Kamath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan Ganesh","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeena","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Mutalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Balaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6653-4660","authenticated-orcid":false,"given":"Nandakumar","family":"Krishnadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110096_bib1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuropharm.2024.110096_bib2","first-page":"1598","article-title":"Alzheimers dement","volume":"19","year":"2023","journal-title":"J. Alzheimers Assoc."},{"key":"10.1016\/j.neuropharm.2024.110096_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030281","article-title":"Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route","volume":"15","author":"Abo El-Enin","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2024.110096_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s12011-021-03073-7","article-title":"Resveratrol-Selenium nanoparticles alleviate neuroinflammation and neurotoxicity in a rat model of alzheimer's disease by regulating sirt1\/miRNA-134\/GSK3\u03b2 expression","volume":"200","author":"Abozaid","year":"2022","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib5","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2014.3034","article-title":"Resveratrol inhibits \u03b2-amyloid-induced neuronal apoptosis via regulation of p53 acetylation in PC12 cells","volume":"11","author":"Ai","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2024.110096_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13936","article-title":"Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways","volume":"45","author":"Akbar","year":"2021","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.neuropharm.2024.110096_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1179573520924311","article-title":"Therapeutic potential of vitamin D and curcumin in an in vitro model of alzheimer disease","volume":"12","author":"Alamro","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.neuropharm.2024.110096_bib8","first-page":"278","article-title":"Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations","volume":"17","author":"Almeida","year":"2014","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib9","article-title":"Alzheimer's association 2024 alzheimer's disease facts and figures","volume":"20","year":"2024","journal-title":"Alzheimers Assoc"},{"key":"10.1016\/j.neuropharm.2024.110096_bib10","author":"Alzheimer\u2019s"},{"key":"10.1016\/j.neuropharm.2024.110096_bib11","series-title":"Phase II Study to Evaluate the Impact on Biomarkers of Resveratrol Treatment in Patients with Mild to Moderate Alzheimer's Disease (Clinical Trial Registration No. NCT01504854)","year":"2016"},{"key":"10.1016\/j.neuropharm.2024.110096_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcme.2016.05.005","article-title":"Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives \u2013 a review","volume":"7","author":"Amalraj","year":"2017","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.neuropharm.2024.110096_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01261","article-title":"Resveratrol brain delivery for neurological disorders prevention and treatment","volume":"9","author":"Andrade","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib14","doi-asserted-by":"crossref","DOI":"10.1088\/1757-899X\/263\/3\/032019","article-title":"A review on the classification, characterisation, synthesis of nanoparticles and their application","volume":"263","author":"Anu Mary Ealia","year":"2017","journal-title":"IOP Conf. Ser. Mater. Sci. Eng."},{"key":"10.1016\/j.neuropharm.2024.110096_bib15","article-title":"Nanotechnology approaches for enhanced CNS delivery in treating Alzheimer's disease","volume":"51","author":"Arya","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107494","article-title":"Nanoparticles of resveratrol attenuates oxidative stress and inflammation after ischemic stroke in rats","volume":"94","author":"Ashafaq","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2024.110096_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00155","article-title":"Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders","volume":"11","author":"Ayaz","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110096_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2147\/NDT.S57909","article-title":"Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease","author":"Baseman","year":"2014","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2024.110096_bib20","series-title":"Natural Polymer Drug Delivery Systems: Nanoparticles, Plants, and Algae","first-page":"33","article-title":"Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications","author":"Bhatia","year":"2016"},{"key":"10.1016\/j.neuropharm.2024.110096_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ma15030804","article-title":"Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.neuropharm.2024.110096_bib22","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","article-title":"Induction of tau pathology by intracerebral infusion of amyloid-\u03b2-containing brain extract and by amyloid-\u03b2 deposition in APP \u00d7 tau transgenic mice","volume":"171","author":"Bolmont","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib56","article-title":"Impacts of FDA approval and Medicare restriction on anti-amyloid therapies for Alzheimer\u2019s disease: patient outcomes, healthcare costs, and drug development","volume":"20","author":"Brockmann","year":"2023","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.neuropharm.2024.110096_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-020-01968-1","article-title":"The immune system on the TRAIL of Alzheimer's disease","volume":"17","author":"Burgaletto","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110096_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer's disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib25","first-page":"303","article-title":"Donepezil in Alzheimer's disease: from conventional trials to pharmacogenetics","volume":"3","author":"Cacabelos","year":"2007","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2024.110096_bib26","doi-asserted-by":"crossref","DOI":"10.2174\/09298673113209990120","article-title":"Bioavailability of quercetin: problems and promises","volume":"20","author":"Cai","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110096_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314835","article-title":"The neuroprotective potentiality of flavonoids on alzheimer's disease","volume":"23","author":"Calderaro","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2019.03.010","article-title":"Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)\/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe\/PS1dE9 Alzheimer's disease mice model","volume":"301","author":"Cano","year":"2019","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.neuropharm.2024.110096_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2006.09.007","article-title":"Trail interacts redundantly with nitric oxide in rat astrocytes: potential contribution to neurodegenerative processes","volume":"182","author":"Cantarella","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu14040819","article-title":"Phenolic acids and prevention of cognitive decline: polyphenols with a neuroprotective role in cognitive disorders and alzheimer's disease","volume":"14","author":"Caruso","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2024.110096_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102294","article-title":"Oxidative stress in alzheimer's disease: a review on emergent natural polyphenolic therapeutics","volume":"49","author":"Cassidy","year":"2020","journal-title":"Compl. Ther. Med."},{"key":"10.1016\/j.neuropharm.2024.110096_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ddc3010011","article-title":"Plant-derived natural products: a source for drug discovery and development","volume":"3","author":"Chaachouay","year":"2024","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.neuropharm.2024.110096_bib33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1039\/c0nr00735h","article-title":"Synthesis, functionalization and bioimaging applications of highly fluorescent carbon nanoparticles","volume":"3","author":"Chandra","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.neuropharm.2024.110096_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2024.110096_bib35","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-011-9632-z","article-title":"Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats","volume":"12","author":"Chen","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.neuropharm.2024.110096_bib36","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110096_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076328","article-title":"The potential benefits of quercetin for brain health: a review of anti-inflammatory and neuroprotective mechanisms","volume":"24","author":"Chiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib38","series-title":"A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease (Clinical Trial Registration No. NCT00164749)","year":"2008"},{"key":"10.1016\/j.neuropharm.2024.110096_bib39","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-190863","article-title":"Molecular mechanisms and genetics of oxidative stress in alzheimer's disease","volume":"72","author":"Cioffi","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2024.110096_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of alzheimer's disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.neuropharm.2024.110096_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2024.110096_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102947","article-title":"Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: a new class of cholinesterase inhibitor for Alzheimer's disease","volume":"88","author":"Dash","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2024.110096_bib45","article-title":"Neuroprotective effects of natural polyphenol-loaded nanoparticles","volume":"63","author":"Dayar","year":"2021","journal-title":"Act. Nerv. Super. Rediviva"},{"key":"10.1016\/j.neuropharm.2024.110096_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102581","article-title":"Inflammatory cascade in alzheimer's disease pathogenesis: a review of experimental findings","volume":"10","author":"de Oliveira","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110096_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2024.110096_bib48","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-08-0024","article-title":"Phase II trial of curcumin in patients with advanced pancreatic cancer","volume":"14","author":"Dhillon","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mito.2022.03.006","article-title":"Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease","volume":"64","author":"Dhiman","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuropharm.2024.110096_bib50","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/cells11172728","article-title":"Role of microglia and astrocytes in alzheimer's disease: from neuroinflammation to Ca2+ homeostasis dysregulation","volume":"11","author":"Di Benedetto","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110096_bib51","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1039\/C1CS15237H","article-title":"The golden age: gold nanoparticles for biomedicine","volume":"41","author":"Dreaden","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's disease","volume":"388","author":"Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2024.110096_bib53","article-title":"The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin","volume":"9","author":"El-Saber Batiha","year":"2020","journal-title":"Foods"},{"key":"10.1016\/j.neuropharm.2024.110096_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2018.1461955","article-title":"Curcumin-loaded plga-peg nanoparticles conjugated with b6 peptide for potential use in alzheimer's disease","volume":"25","author":"Fan","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.neuropharm.2024.110096_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.809706","article-title":"Epigallocatechin-3-Gallate delivery in lipid-based nanoparticles: potentiality and perspectives for future applications in cancer chemoprevention and therapy","volume":"13","author":"Farabegoli","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2019.09.032","article-title":"Curcumin-loaded nanocapsules reverses the depressant-like behavior and oxidative stress induced by \u03b2-amyloid in mice","volume":"423","author":"Fidelis","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110096_bib58","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S235969","article-title":"Chlorogenic acid alleviates A\u03b225-35-induced autophagy and cognitive impairment via the mTOR\/TFEB signaling pathway","volume":"14","author":"Gao","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2024.110096_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146325","article-title":"Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by \u03b2-amyloid 1-42 peptide in aged female mice","volume":"1721","author":"Giacomeli","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.10.017","article-title":"Terpenoid-rich Elettaria cardamomum extract prevents Alzheimer-like alterations induced in diabetic rats via inhibition of GSK3\u03b2 activity, oxidative stress and pro-inflammatory cytokines","volume":"113","author":"Gomaa","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2024.110096_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8152373","article-title":"Review article neuroprotective mechanisms of resveratrol in alzheimer \u2019 s disease : role of SIRT1","volume":"2018","author":"Gomes","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib62","series-title":"Pilot Study to Investigate the Safety and Feasibility of Senolytic Therapy to Modulate Progression of Alzheimer's Disease (SToMP-AD) (Clinical Trial Registration No. NCT04063124)","author":"Gonzales","year":"2023"},{"key":"10.1016\/j.neuropharm.2024.110096_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111729","article-title":"Mechanistic insights and perspectives involved in nfeuroprotective action of quercetin","volume":"140","author":"Grewal","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2024.110096_bib64","series-title":"Lipid Nanocarriers for Drug Targeting","author":"Grumezescu","year":"2018"},{"key":"10.1016\/j.neuropharm.2024.110096_bib65","article-title":"Nanocarriers as potential drug delivery candidates for overcoming the blood-brain barrier: challenges and possibilities","volume":"5","author":"Guillama Barroso","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.neuropharm.2024.110096_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ph15081008","article-title":"Neuroprotective effects of phytochemicals against aluminum chloride-induced alzheimer's disease through ApoE4\/LRP1, wnt3\/\u03b2-catenin\/gsk3\u03b2, and TLR4\/NLRP3 pathways with physical and mental activities in a rat model","volume":"15","author":"Hamdan","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuropharm.2024.110096_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2020.1745328","article-title":"Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems","volume":"27","author":"Han","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.neuropharm.2024.110096_bib68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40780-015-0014-7","article-title":"Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia","volume":"1","author":"Hashiguchi","year":"2015","journal-title":"J. Pharm. Health Care Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib69","article-title":"Design of epigallocatechin gallate loaded PLGA\/PF127 nanoparticles and their effect upon an oxidative stress model","volume":"48","author":"Hoyos-Ceballos","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1228679","article-title":"Recent progress of nanomedicine in the treatment of Alzheimer's disease","volume":"11","author":"Hu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2018.11.008","article-title":"A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer's disease","volume":"190","author":"Huo","year":"2019","journal-title":"J. Photochem. Photobiol., B"},{"key":"10.1016\/j.neuropharm.2024.110096_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/S0197-4580(97)00066-3","article-title":"The neuropathological diagnosis of Alzheimer's disease: clinical- pathological studies","volume":"18","author":"Hyman","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2024.110096_bib73","series-title":"Oxidative Stress and Dietary Antioxidants in Neurological Diseases","article-title":"Berberine neuroprotection and antioxidant activity","author":"Imenshahidi","year":"2020"},{"key":"10.1016\/j.neuropharm.2024.110096_bib74","article-title":"Transferrin functionalized nanostructured lipid carriers for targeting Rivastigmine and Resveratrol to Alzheimer's disease: synthesis, in vitro characterization and brain uptake analysis","volume":"86","author":"Jain","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of alzheimer's disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2024.110096_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer's disease: a systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib77","series-title":"A Phase II, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of Two Doses of Curcumin C3 Complex Versus Placebo in Patients With Mild to Moderate Alzheimer\u2019s Disease","year":"2009"},{"key":"10.1016\/j.neuropharm.2024.110096_bib78","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib79","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib80","article-title":"Pathological mechanisms and therapeutic strategies for Alzheimer's disease","volume":"17","author":"Ju","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib81","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2018.1428243","article-title":"Therapeutic strategies and nano-drug delivery applications in management of ageing alzheimer's disease","volume":"25","author":"Karthivashan","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.neuropharm.2024.110096_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2009.06562.x","article-title":"Naturally occurring phytochemicals for the prevention of Alzheimer's disease","volume":"112","author":"Kim","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110096_bib83","doi-asserted-by":"crossref","DOI":"10.1080\/20002297.2022.2131117","article-title":"Effects of green tea extract epigallocatechin-3-gallate (EGCG) on oral disease-associated microbes: a review","volume":"14","author":"Kong","year":"2022","journal-title":"J. Oral Microbiol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib84","series-title":"Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health","article-title":"Catechins, neuroprotection, and brain mitochondria","author":"Kopustinskiene","year":"2021"},{"key":"10.1016\/j.neuropharm.2024.110096_bib85","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3390\/molecules24162930","article-title":"Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects","volume":"24","author":"Kotha","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110096_bib86","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.neuro.051508.135600","article-title":"The glial nature of embryonic and adult neural stem cells","volume":"32","author":"Kriegstein","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib87","first-page":"145","article-title":"Challenges in drug delivery to the brain: nature is against us. J. Controlled release, drug delivery and cancer: today's challenges","volume":"164","author":"Krol","year":"2012","journal-title":"Tomorrow\u2019s Directions."},{"key":"10.1016\/j.neuropharm.2024.110096_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00305","article-title":"Nanotheranostic applications for detection and targeting neurodegenerative diseases","volume":"14","author":"Kumar","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib89","article-title":"Neuroprotective potential of phytochemicals. Pharmacogn","volume":"6","author":"Kumar","year":"2012","journal-title":"Rev. E."},{"key":"10.1016\/j.neuropharm.2024.110096_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05546","article-title":"Casuarictin: a new herbal drug molecule for Alzheimer's disease as inhibitor of presenilin stabilization factor like protein","volume":"6","author":"Kumari","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.neuropharm.2024.110096_bib91","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuropharm.2024.110096_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib93","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/alz.12928","article-title":"Prevalence of dementia in India: national and state estimates from a nationwide study","volume":"19","author":"Lee","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuropharm.2024.110096_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00472","article-title":"Meta-analysis of randomized controlled trials on the efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of alzheimer's disease","volume":"13","author":"Li","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2019.08.194","article-title":"Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: studies in a transgenic mouse model of Alzheimer's disease","volume":"82","author":"Li","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2024.110096_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116364","article-title":"Sanwei DouKou Decoction ameliorate Alzheimer disease by increasing endogenous neural stem cells proliferation through the Wnt\/\u03b2-catenin signalling pathway","volume":"309","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib97","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/cells11121925","article-title":"New insights into neuroinflammation involved in pathogenic mechanism of alzheimer's disease and its potential for therapeutic intervention","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2024.110096_bib98","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110096_bib99","series-title":"Senolytics to Alleviate Mobility Issues and Neurological Impairment in Aging (Clinical Trial Registration No. NCT05422885)","author":"Lipsitz","year":"2024"},{"key":"10.1016\/j.neuropharm.2024.110096_bib100","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3389\/fphar.2019.01688","article-title":"An updated review of randomized clinical trials testing the improvement of cognitive function of ginkgo biloba extract in healthy people and alzheimer's patients","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib101","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1586\/ern.11.132","article-title":"Use of memantine for the treatment of dementia","volume":"11","author":"Lo","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2024.110096_bib102","article-title":"Galactosylated nanoconstructs of Berberine with enhanced Biopharmaceutical and cognitive potential: a preclinical evidence in Alzheimer \u2018s disease","volume":"66","author":"Lohan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2011.09.004","article-title":"Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine","volume":"1822","author":"Mancuso","year":"2012","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2024.110096_bib104","doi-asserted-by":"crossref","DOI":"10.5812\/ipmn.117170","article-title":"Neuroprotective role of polyphenols in treatment of neurological disorders: a review","volume":"1","author":"Maqbool","year":"2021","journal-title":"Interv. Pain Med. Neuromodulation"},{"key":"10.1016\/j.neuropharm.2024.110096_bib105","doi-asserted-by":"crossref","DOI":"10.1039\/D0BM00809E","article-title":"Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases","volume":"8","author":"Masoudi Asil","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123289","article-title":"Memantine monotherapy for alzheimer's disease: a systematic review and meta-analysis","volume":"10","author":"Matsunaga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110096_bib107","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1021\/es8006904","article-title":"Environmental applications of carbon-based nanomaterials","volume":"42","author":"Mauter","year":"2008","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib108","article-title":"Randomized, placebo-controlled clinical trial of resveratrol supplement effects on cognition, function and behavior in patients with mild-to-moderate alzheimer's disease (clinical trial registration No. NCT00743743)","year":"2015","journal-title":"clinicaltrials.gov"},{"key":"10.1016\/j.neuropharm.2024.110096_bib109","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/0019-5545.104820","article-title":"Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer's disease: findings of an observational study","volume":"54","author":"Mehta","year":"2012","journal-title":"Indian J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110096_bib110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/nano.202300038","article-title":"Nanomaterials: an overview of synthesis, classification, characterization, and applications","volume":"4","author":"Mekuye","year":"2023","journal-title":"Nano Sel"},{"key":"10.1016\/j.neuropharm.2024.110096_bib111","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6038996","article-title":"Flavonoids as promising neuroprotectants and their therapeutic potential against alzheimer's disease","volume":"2022","author":"Minocha","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib112","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.2c06215","article-title":"Intranasally Co-administered berberine and curcumin loaded in transfersomal vesicles improved inhibition of amyloid formation and BACE-1","volume":"7","author":"Mishra","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.neuropharm.2024.110096_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-023-03955-3","article-title":"Recent advancements in nanocarrier-assisted brain delivery of phytochemicals against neurological diseases","volume":"48","author":"Mishra","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib114","doi-asserted-by":"crossref","DOI":"10.1039\/D0NR06249A","article-title":"Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage","volume":"13","author":"Mo","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.neuropharm.2024.110096_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2016.11.061","article-title":"Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease","volume":"517","author":"Moreno","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuropharm.2024.110096_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","article-title":"State of the art of nanocrystals \u2013 special features, production, nanotoxicology aspects and intracellular delivery","volume":"78","author":"M\u00fcller","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.neuropharm.2024.110096_bib117","doi-asserted-by":"crossref","DOI":"10.2147\/DDDT.S289473","article-title":"Epigallocatechin-3-gallate provides protection against alzheimer's disease-induced learning and memory impairments in rats","volume":"15","author":"Nan","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2024.110096_bib118","doi-asserted-by":"crossref","DOI":"10.5640\/insc.0104169","article-title":"Nanotechnology for Alzheimer's disease detection and treatment","volume":"1","author":"Nazem","year":"2011","journal-title":"Insciences J"},{"key":"10.1016\/j.neuropharm.2024.110096_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101542","article-title":"Drug penetration into the central nervous system: pharmacokinetic concepts and in vitro model systems","volume":"13","author":"Neumaier","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2024.110096_bib120","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1021\/acs.chemrev.5b00140","article-title":"Molecular interactions in organic nanoparticles for phototheranostic applications","volume":"115","author":"Ng","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib121","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/pharmaceutics13050670","article-title":"Polymeric and lipid nanoparticles: which applications in pediatrics?","volume":"13","author":"Nieto Gonz\u00e1lez","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2024.110096_bib122","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3164\/jcbn.21-17","article-title":"The effect of 24-week continuous intake of quercetin-rich onion on age-related cognitive decline in healthy elderly people: a randomized, double-blind, placebo-controlled, parallel-group comparative clinical trial","volume":"69","author":"Nishihira","year":"2021","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.neuropharm.2024.110096_bib123","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.biomaterials.2009.10.018","article-title":"Size control of magnetic carbon nanoparticles for drug delivery","volume":"31","author":"Oh","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.neuropharm.2024.110096_bib124","series-title":"Global Status Report on the Public Health Response to Dementia","author":"Organization","year":"2021"},{"key":"10.1016\/j.neuropharm.2024.110096_bib125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914794","article-title":"Amyloid precursor protein and alzheimer's disease","volume":"24","author":"Orobets","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00284","article-title":"Phyto-therapeutic and nanomedicinal approaches to cure alzheimer's disease: present status and future opportunities","volume":"10","author":"Ovais","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib127","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-food-041715-033215","article-title":"Organic nanoparticles in foods: fabrication, characterization, and utilization","volume":"7","author":"Pan","year":"2016","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib128","series-title":"Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer's Disease (Clinical Trial Registration No. NCT00951834)","author":"Paul","year":"2021"},{"key":"10.1016\/j.neuropharm.2024.110096_bib129","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s43587-022-00310-z","article-title":"Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer's disease pathology","volume":"2","author":"Pereira","year":"2022","journal-title":"Nat. Aging"},{"key":"10.1016\/j.neuropharm.2024.110096_bib130","article-title":"RVG29-Functionalized lipid nanoparticles for quercetin brain delivery and alzheimer's disease","volume":"37","author":"Pinheiro","year":"2020","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.neuropharm.2024.110096_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105314","article-title":"Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease","volume":"148","author":"Pinheiro","year":"2020","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.125058","article-title":"Quercetin-loaded selenium nanoparticles inhibit amyloid-\u03b2 aggregation and exhibit antioxidant activity","volume":"602","author":"Qi","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.neuropharm.2024.110096_bib133","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer's disease: role of SIRT1","volume":"2018","author":"Quadros Gomes","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.619024","article-title":"Resveratrol and neuroprotection: impact and its therapeutic potential in alzheimer's disease","volume":"11","author":"Rahman","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104881","article-title":"A critical review on quercetin bioflavonoid and its derivatives: scope, synthesis, and biological applications with future prospects","volume":"16","author":"Rajesh R","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.neuropharm.2024.110096_bib136","article-title":"Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: formulation, optimization and in vivo characterization","volume":"51","author":"Rajput","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2019.103517","article-title":"Therapeutic potential and recent delivery systems of berberine: a wonder molecule","volume":"61","author":"Raju","year":"2019","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.neuropharm.2024.110096_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119990","article-title":"Berberine loaded nanostructured lipid carrier for Alzheimer's disease: design, statistical optimization and enhanced in vivo performance","volume":"285","author":"Raju","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib139","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1212\/WNL.0000000000207757","article-title":"Antiamyloid monoclonal antibody therapy for alzheimer disease","volume":"101","author":"Ramanan","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2024.110096_bib140","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1080\/10408398.2022.2070906","article-title":"An updated and comprehensive review on the potential health effects of curcumin-encapsulated micro\/nanoparticles","volume":"63","author":"Rashwan","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.neuropharm.2024.110096_bib141","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/molecules27103194","article-title":"Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases","volume":"27","author":"Rauf","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110096_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in alzheimer's disease and other tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib143","series-title":"FDA Approves Treatment for Adults with Alzheimer's Disease","year":"2024"},{"key":"10.1016\/j.neuropharm.2024.110096_bib144","series-title":"FDA Approves Treatment for Adults with Alzheimer's Disease","year":"2024"},{"key":"10.1016\/j.neuropharm.2024.110096_bib145","series-title":"Aducanumab (Marketed as Aduhelm) Information","year":"2022"},{"key":"10.1016\/j.neuropharm.2024.110096_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101795","article-title":"Neuroprotective effect of quercetin nanoparticles: a possible prophylactic and therapeutic role in alzheimer's disease","volume":"107","author":"Rifaai","year":"2020","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuropharm.2024.110096_bib147","doi-asserted-by":"crossref","DOI":"10.1007\/s13318-018-0517-3","article-title":"Improved oral absorption of quercetin from quercetin Phytosome\u00ae, a new delivery system based on food grade lecithin","volume":"44","author":"Riva","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2024.110096_bib148","doi-asserted-by":"crossref","DOI":"10.2174\/13816128113199990613","article-title":"Targeted drug delivery across the blood brain barrier in alzheimer's disease","volume":"19","author":"Rocha","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2024.110096_bib149","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2024.110096_bib150","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4838043","article-title":"An overview of nanomaterial applications in pharmacology","volume":"2023","author":"Roy","year":"2023","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2024.110096_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2015.01.027","article-title":"The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice","volume":"93","author":"Sabogal-Gu\u00e1queta","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110096_bib152","doi-asserted-by":"crossref","DOI":"10.2174\/1389201021666200130113441","article-title":"Current prospects of nutraceuticals: a review","volume":"21","author":"Sachdeva","year":"2020","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib153","doi-asserted-by":"crossref","DOI":"10.1080\/1061186X.2019.1608553","article-title":"Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles: in vivo evaluation and bioaccumulation investigation using computed tomography and histopathological examination","volume":"27","author":"Salem","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.neuropharm.2024.110096_bib154","series-title":"StatPearls","article-title":"Physiology, acetylcholine","author":"Sam","year":"2024"},{"key":"10.1016\/j.neuropharm.2024.110096_bib155","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-018-0356-z","article-title":"Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization","volume":"16","author":"S\u00e1nchez-L\u00f3pez","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10040232","article-title":"Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review","volume":"10","author":"Schaffert","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12091515","article-title":"Multi-target mechanisms of phytochemicals in alzheimer's disease: effects on oxidative stress, neuroinflammation and protein aggregation","volume":"12","author":"Sharifi-Rad","year":"2022","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.neuropharm.2024.110096_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01021","article-title":"Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098148","article-title":"Multi-targeting neuroprotective effects of Syzygium aromaticum Bud extracts and their key phytocompounds against neurodegenerative diseases","volume":"24","author":"Sharma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib160","first-page":"1","article-title":"Potential implications of polyphenolic compounds in neurodegenerative diseases","author":"Shi","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.neuropharm.2024.110096_bib161","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-019-0541-9","article-title":"Amyloid \u03b2-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation","volume":"11","author":"Shin","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2024.110096_bib162","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.drudis.2021.04.011","article-title":"Nanotechnological approaches for targeting amyloid-\u03b2 aggregation with potential for neurodegenerative disease therapy and diagnosis","volume":"26","author":"Shukla","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuropharm.2024.110096_bib163","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1208\/s12249-022-02393-8","article-title":"Fabrication of TPGS-grafted polyamidoamine dendrimer for enhanced piperine brain delivery and pharmacokinetics","volume":"23","author":"Singh","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.neuropharm.2024.110096_bib164","doi-asserted-by":"crossref","DOI":"10.1021\/acsbiomaterials.1c00514","article-title":"Lipid-Coated MCM-41 mesoporous silica nanoparticles loaded with berberine improved inhibition of acetylcholine esterase and amyloid formation","volume":"7","author":"Singh","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.neuropharm.2024.110096_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00244","article-title":"EGCG nanoparticles attenuate aluminum chloride induced neurobehavioral deficits, beta amyloid and tau pathology in a rat model of Alzheimer's disease","volume":"10","author":"Singh","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2023.07.004","article-title":"Emerging nanotechnology for Alzheimer's disease: from detection to treatment","volume":"360","author":"Song","year":"2023","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.neuropharm.2024.110096_bib167","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-019-00626-1","article-title":"Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study","volume":"9","author":"Soudi","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020272","article-title":"Neurogenic traditional Chinese medicine as a promising strategy for the treatment of alzheimer's disease","volume":"18","author":"Sreenivasmurthy","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib169","series-title":"NeuroPsychopharmacotherapy","first-page":"2709","article-title":"Acetylcholinesterase inhibitors (galantamine, rivastigmine, and donepezil)","author":"Sridhar","year":"2022"},{"key":"10.1016\/j.neuropharm.2024.110096_bib170","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-012-0940-9","article-title":"Neuroprotective potential of epigallo catechin-3-gallate in PC-12 cells","volume":"38","author":"Srividhya","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib171","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib172","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02182-3","article-title":"Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease","volume":"18","author":"Sun","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110096_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101715","article-title":"Improving curcumin bioavailability: current strategies and future perspectives","volume":"13","author":"Tabanelli","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2024.110096_bib174","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1021\/ie060869b","article-title":"Synthesis of magnesium hydroxide and oxide nanoparticles using a spinning disk reactor","volume":"46","author":"Tai","year":"2007","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109604","article-title":"Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects","volume":"121","author":"Tang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2024.110096_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.02.015","article-title":"Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis","volume":"127","author":"Teter","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110096_bib177","article-title":"Increasing awareness of the need for brain health","volume":"23","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib178","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt\/\u03b2-catenin pathway","volume":"8","author":"Tiwari","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuropharm.2024.110096_bib179","doi-asserted-by":"crossref","DOI":"10.1179\/016164105X49463","article-title":"Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge","volume":"27","author":"Tonelli","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173412","article-title":"Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration","volume":"886","author":"Uddin","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib181","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/504253","article-title":"Role of polyphenols and other phytochemicals on molecular signaling","volume":"2015","author":"Upadhyay","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib182","article-title":"GSK3 and alzheimer's disease: facts and fiction\u2026","volume":"4","author":"Vanleuven","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib183","doi-asserted-by":"crossref","first-page":"566","DOI":"10.25259\/JNRP_356_2023","article-title":"Guidelines for pharmacotherapy in Alzheimer's disease \u2013 a primer on FDA-approved drugs","volume":"14","author":"Varadharajan","year":"2023","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.neuropharm.2024.110096_bib184","article-title":"Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease","volume":"18","author":"Wang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00181-0","article-title":"The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice","volume":"22","author":"Wegiel","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2024.110096_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2018.07.084","article-title":"Anticholinergic effects of Actinidia arguta fruits and their polyphenol content determined by liquid chromatography-photodiode array detector-quadrupole\/time of flight-mass spectrometry (LC-MS-PDA-Q\/TOF)","volume":"271","author":"Wojdy\u0142o","year":"2019","journal-title":"Food Chem."},{"key":"10.1016\/j.neuropharm.2024.110096_bib187","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/acsnano.9b08133","article-title":"Nanomaterials for nanotheranostics: tuning their properties according to disease needs","volume":"14","author":"Wong","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuropharm.2024.110096_bib188","series-title":"WHO Reveals Leading Causes of Death and Disability Worldwide: 2000-2019","year":"2020"},{"key":"10.1016\/j.neuropharm.2024.110096_bib189","article-title":"In vitro and in silico analysis of phytochemicals from fallopia dentatoalata as dual functional cholinesterase inhibitors for the treatment of alzheimer's disease","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib190","article-title":"Functionalized curcumin\/ginsenoside Rb1 dual-loaded liposomes: targeting the blood-brain barrier and improving pathological features associated in APP\/PS-1 mice","volume":"86","author":"Yan","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111263","article-title":"The flavonoids of okra insulates against oxidative stress, neuroinflammation and restores BDNF levels in A\u03b21\u201342 induced mouse model of Alzheimer's disease","volume":"147","author":"Yan","year":"2021","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neuropharm.2024.110096_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120714","article-title":"Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease","volume":"310","author":"Yang","year":"2023","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.neuropharm.2024.110096_bib193","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4754195","article-title":"Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3 \u03b2 pathway in experimental models of alzheimer's disease","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib194","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S208332","article-title":"Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders","volume":"14","author":"Yavarpour-Bali","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuropharm.2024.110096_bib195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2019.08.008","article-title":"Pharmacokinetics of nanotechnology-based formulations in pediatric populations","volume":"2019","author":"Yellepeddi","year":"2019","journal-title":"Adv. Drug Deliv. Rev., Editor\u2019s Collection"},{"key":"10.1016\/j.neuropharm.2024.110096_bib196","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900389","article-title":"Tea consumption and health outcomes: umbrella review of meta-analyses of observational studies in humans","volume":"63","author":"Yi","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.neuropharm.2024.110096_bib197","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8887716","article-title":"Linalool alleviates A \u03b2 42-induced neurodegeneration via suppressing ROS production and inflammation in fly and rat models of alzheimer's disease","volume":"2021","author":"Yuan","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110096_bib198","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","article-title":"Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer's disease model","volume":"21","author":"Yusuf","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.neuropharm.2024.110096_bib199","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/w13162216","article-title":"A review on silver nanoparticles: classification, various methods of synthesis, and their potential roles in biomedical applications and water treatment","volume":"13","author":"Zahoor","year":"2021","journal-title":"Water"},{"key":"10.1016\/j.neuropharm.2024.110096_bib200","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1021\/acs.molpharmaceut.0c00675","article-title":"In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly(lactic-co-glycolic acid) nanoparticles and curcumin\/hydroxypropyl-\u03b2-cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuropharm.2024.110096_bib201","article-title":"Phosphorylation signaling in APP processing in Alzheimer's disease","volume":"21","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110096_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2024.110096_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2017.11.065","article-title":"LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo","volume":"642","author":"Zhao","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2024.110096_bib204","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02248-5","article-title":"Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus","volume":"11","author":"Zu","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400265X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400265X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T19:56:03Z","timestamp":1732478163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082400265X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":202,"alternative-id":["S002839082400265X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110096","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110096"}}